Literature DB >> 12477811

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Robert Thimme1, Stefan Wieland, Carola Steiger, John Ghrayeb, Keith A Reimann, Robert H Purcell, Francis V Chisari.   

Abstract

Although the CD4(+)- and CD8(+)-T-cell responses to the hepatitis B virus (HBV) are thought to be crucial for the control of HBV infection, the relative contribution of each T-cell subset as an effector of viral clearance is not known. To examine this question, we monitored the course of HBV infection in control, CD4-depleted, and CD8-depleted chimpanzees. Our results demonstrate that CD8(+) cells are the main effector cells responsible for viral clearance and disease pathogenesis during acute HBV infection, and they suggest that viral clearance is mediated by both noncytolytic and cytolytic effector functions of the CD8(+)-T-cell response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477811      PMCID: PMC140637          DOI: 10.1128/jvi.77.1.68-76.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

Authors:  L G Guidotti; T Ishikawa; M V Hobbs; B Matzke; R Schreiber; F V Chisari
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

2.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees.

Authors:  M Jonker; W Slingerland; G Treacy; P van Eerd; K Y Pak; E Wilson; S Tam; K Bakker; A F Lobuglio; P Rieber
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

4.  Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice.

Authors:  L G Guidotti; V Martinez; Y T Loh; C E Rogler; F V Chisari
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.

Authors:  C Ferrari; A Penna; T Giuberti; M J Tong; E Ribera; F Fiaccadori; F V Chisari
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

6.  Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

Authors:  M Battegay; D Moskophidis; A Rahemtulla; H Hengartner; T W Mak; R M Zinkernagel
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte.

Authors:  K Kajino; A R Jilbert; J Saputelli; C E Aldrich; J Cullen; W S Mason
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  High-level hepatitis B virus replication in transgenic mice.

Authors:  L G Guidotti; B Matzke; H Schaller; F V Chisari
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.

Authors:  B Rehermann; D Lau; J H Hoofnagle; F V Chisari
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.

Authors:  B Rehermann; P Fowler; J Sidney; J Person; A Redeker; M Brown; B Moss; A Sette; F V Chisari
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  363 in total

Review 1.  Role of interleukin-21 in HBV infection: friend or foe?

Authors:  Yongyin Li; Libo Tang; Jinlin Hou
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

2.  Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice.

Authors:  Tong-Dong Shi; Yu-Zhang Wu; Zheng-Cai Jia; Wei Zhou; Li-Yun Zou
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

3.  Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.

Authors:  N Obeng-Adjei; D K Choo; J Saini; J Yan; P Pankhong; A Parikh; J S Chu; D B Weiner
Journal:  Cancer Gene Ther       Date:  2012-10-05       Impact factor: 5.987

4.  Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice.

Authors:  Roman R Ganta; Chuanmin Cheng; Melinda J Wilkerson; Stephen K Chapes
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Authors:  John R Mascola; Mark G Lewis; Thomas C VanCott; Gabriela Stiegler; Hermann Katinger; Michael Seaman; Kristin Beaudry; Dan H Barouch; Birgit Korioth-Schmitz; Georgia Krivulka; Anna Sambor; Brent Welcher; Daniel C Douek; David C Montefiori; John W Shiver; Pascal Poignard; Dennis R Burton; Norman L Letvin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors:  S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 7.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 8.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).

Authors:  Heather W Stout-Delgado; Yonas Getachew; Bonnie C Miller; Dwain L Thiele
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

10.  Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice.

Authors:  Matthew Giannandrea; Robert H Pierce; Ian Nicholas Crispe
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.